Greenwich Lifesciences Inc (GLSI NASDAQ) stock market data APIs
$22.4897
-0.34(-1.5%)
as of May 5, 2026
Try our APIs with
free plan!
Greenwich Lifesciences Inc Financial Data Overview
Price chart is built with
Anychart
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2 positive breast cancer patients. Greenwich LifeSciences, Inc. was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. The company was incorporated in 2006 and is headquartered in Stafford, Texas.
Prev. Close
22.4897
Open
22.1532
High
22.6722
Low
21.3507
52 wk Range
7.78-34.1
Market Cap
309 M
Shares Outstanding
13 855 K
EPS
0
Beta
1.385
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Greenwich Lifesciences Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Greenwich Lifesciences Inc data using free add-ons & libraries
Get Greenwich Lifesciences Inc Fundamental Data
Greenwich Lifesciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -19 584 406
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Greenwich Lifesciences Inc Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-02-25
- EPS/Forecast: -0.34
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Greenwich Lifesciences Inc News
New
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
STAFFORD, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, F...
Greenwich LifeSciences Highlights Phase III FLAMINGO-01 Data At AACR 2026
(RTTNews) - Greenwich LifeSciences, Inc. (GLSI) presented new open-label data from its pivotal Phase III FLAMINGO-01 trial of GLSI-100, an immunotherapy designed to prevent breast cancer recurrences, ...
3 things to look out for on Monday
[NOUVEL YORK CITY, USA] U.S. stocks closed mixed on Friday, with the S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500]) and the Dow Jones (DJI [https://seekingalpha.com/symbol/DJI]) ending lower...
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
STAFFORD, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, F...
Get Greenwich Lifesciences Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
